CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
February 2020—Codexis, a protein engineering company, announced a license agreement to provide Roche with its EvoT4 DNA ligase high-performance molecular diagnostic enzyme. The enzyme was developed using Codexis’ CodeEvolver protein engineering platform and is expected to be incorporated into Roche’s next-generation sequencing library preparation kits and other sequencing products. The license grants Roche worldwide rights to include the EvoT4 DNA ligase in its nucleic acid sequencing products and workflows.
The EvoT4 DNA ligase was developed to improve the efficiency and speed of adapter ligation for challenging and low-input DNA samples.
Pages: 1 2